The markets once again traded in a range today ahead of the Federal Reserve meeting tomorrow, but were able to squeeze out a gain. The Dow 30 added 26, the S&P 500 was flat, and the Nasdaq 100 added 6. Tomorrow the focus will be squarely on the Fed as traders anxiously await their decision to raise rates, or leave them be.

Wells Fargo (WFC  ) CEO John Stumpf was on Capitol Hill today to answer questions about the scandal over the fraudulent accounts set up by the bank's employees to meet sales targets. Wells has already paid $185 million in penalties and fired 5,300 people involved. On the hill today, Stumpf told the Senate Banking Committee he's "deeply sorry" and takes "full responsibility" for the unethical behavior. He also attempted to make it clear that there was "no orchestrated effort or scheme" by the bank to encourage the allegedly illegal sales practices. Shares of the bank were higher today by 1.22% as Morgan Stanley (MS  ) helped them out with an upgrade.

Apple (AAPL  ) fairly active once again today after UBS raised its 12-month price target on the stock to $127 per share from $115. The bank cited expectations of higher 2017 earnings and demand for the new iPhone 7, which has been encouraging. Apple shares popped last week on optimism over pre-orders, but today it closed flat, in the middle of the days range, down 0.01%.

Chesapeake Energy (CHK  ) shares fell 3.67% early today following news late Monday that billionaire investor Carl Icahn cut his stake in the shale driller by more than half to 4.5%. Icahn said he reduced his position for tax reasons and expressed confidence in Chesapeake's top executives. This was not enough to convince investors not to follow in Mr. Icahn's footsteps.

SeaWorld (SEAS  ) shares fell to new 52 week lows this morning (-4.49%) after the embattled theme park operator said it will suspend future dividend payments. The company said it would use the money saved on dividend payments to buy back shares. SeaWorld said it would stop breeding killer whales in March as public scrutiny over its treatment of orcas took a toll on attendance in recent years.